FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3096066812> ?p ?o ?g. }

• W3096066812 endingPage "15" @default.
• W3096066812 startingPage "14" @default.
• W3096066812 abstract "Background The Philadelphia chromosome t(9;22), a reciprocal translocation between chromosomes 9 and 22, results in the gene fusion BCR-ABL1, and occurs in 2-3% of childhood acute lymphoblastic leukemia (ALL). It is detected using cytogenetic and molecular techniques: karyotype, fluorescence in-situ hybridization (FISH) for t(9;22) and reverse transcription polymerase chain reaction (RT-PCR) for BCR-ABL1. Detection has implications for treatment, with the addition of tyrosine kinase inhibitors to chemotherapy regimens improving outcome. Low level BCR-ABL1 transcripts have been reported in blood of healthy individuals. We have observed this finding in bone marrow in newly diagnosed ALL in the absence of the t(9;22) by karyotype or FISH. The significance of low level positivity at diagnosis has not been determined in the setting of childhood Philadelphia chromosome negative (Ph-) ALL. Here we report, for the first time, the molecular evolutionary characteristics of children and adolescents with low level BCR-ABL1 positivity found at diagnosis to relapse. Methods We reviewed 327 patients aged 0-17 years diagnosed with ALL or Acute Leukemia of Ambiguous lineage (ALAL) at The Children's Hospital at Westmead, Sydney, Australia from 1 January 2010 to 30 June 2020. Those positive for the BCR-ABL1 gene fusion by RT-PCR, and negative for t(9;22) by karyotype or FISH were included. Demographics, cytogenetics at diagnosis and relapse, and outcome data were extracted from the medical record. Qualitative BCR-ABL1 analysis was performed using multiplex RT-PCR, followed by nested PCR, on RNA extracted from diagnostic bone marrow (sensitivity 5x10-6). If positive, quantitation was performed using real-time RT-PCR with results expressed as the ratio of BCR-ABL1 over ABL1 (sensitivity 1x10-5). Each PCR included positive and negative controls. Results Of 313 (96%) evaluable patients diagnosed with ALL or ALAL at our institution in the study period, 54 (17%) were positive by RT-PCR for BCR-ABL1 in diagnostic bone marrow. Seven patients were excluded as they had Ph+ ALL-specific treatment after the detection of t(9;22) by karyotype, FISH or other methods. Forty-seven (15%) children with Ph- ALL had low level BCR-ABL1 detected by qualitative PCR. Demographic and cytogenetic characteristics for these patients are summarized in Table 1. All were diagnosed with ALL, the majority (77%) of precursor B-cell lineage including 2 with infant ALL. The e1a2 transcript was identified in 43 (91%) patients, with other transcript types as follows: e4a2 in 1 (2%), e13a2 in 1 (2%), and splicing variants in 2 (4%). BCR-ABL1 quantitation was performed in 43 (91%) and was quantifiable only in 12 (28%) patients, with a median of 0.0008% (range 0.0003 - 0.095%). Forty-five (96%) patients were treated with Berlin-Frankfurt-Munster ALL chemotherapy regimens. The two infant ALL patients were treated on the Interfant06 trial. One received a bone marrow transplant (BMT) in first remission then died after relapse; the other relapsed and died before BMT. Seven (15%) of 47 relapsed, occurring at a median of 21 months (range 2 - 41 months) after diagnosis. Characteristics of these patients are presented in Table 2. Four patients were tested for BCR-ABL1 by RT-PCR in relapse marrow samples; all were negative. No patient with low level BCR-ABL1 positivity at initial diagnosis was diagnosed with Ph+ ALL at relapse. There was no difference in 5-year relapse-free (80% vs 83%, P = .451) or overall survival (86% vs 91%, P = .368) between children with low level BCR-ABL1 positivity (n=47) and those without (n=259). Conclusion BCR-ABL1 low level positivity detected by RT-PCR in the bone marrow of children with newly diagnosed ALL is a relatively common finding, and did not adversely affect outcome for patients treated for Ph- ALL using a contemporary risk-adapted approach. Importantly, this finding did not influence the molecular evolutionary characteristics at the time of relapse in our patient group. Disclosures No relevant conflicts of interest to declare." @default.
• W3096066812 created "2020-11-09" @default.
• W3096066812 creator A5005404102 @default.
• W3096066812 creator A5011570520 @default.
• W3096066812 creator A5016102397 @default.
• W3096066812 creator A5030501684 @default.
• W3096066812 creator A5032347797 @default.
• W3096066812 creator A5058698993 @default.
• W3096066812 creator A5064696468 @default.
• W3096066812 creator A5067585076 @default.
• W3096066812 creator A5073813408 @default.
• W3096066812 creator A5079603574 @default.
• W3096066812 date "2020-11-05" @default.
• W3096066812 modified "2023-09-27" @default.
• W3096066812 title "Low Level BCR-ABL1 Gene Fusion Detected By RT-PCR in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia Does Not Predict Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia at Relapse: A 10-Year Single Institution Study" @default.
• W3096066812 doi "https://doi.org/10.1182/blood-2020-139359" @default.
• W3096066812 hasPublicationYear "2020" @default.
• W3096066812 type Work @default.
• W3096066812 sameAs 3096066812 @default.
• W3096066812 citedByCount "0" @default.
• W3096066812 crossrefType "journal-article" @default.
• W3096066812 hasAuthorship W3096066812A5005404102 @default.
• W3096066812 hasAuthorship W3096066812A5011570520 @default.
• W3096066812 hasAuthorship W3096066812A5016102397 @default.
• W3096066812 hasAuthorship W3096066812A5030501684 @default.
• W3096066812 hasAuthorship W3096066812A5032347797 @default.
• W3096066812 hasAuthorship W3096066812A5058698993 @default.
• W3096066812 hasAuthorship W3096066812A5064696468 @default.
• W3096066812 hasAuthorship W3096066812A5067585076 @default.
• W3096066812 hasAuthorship W3096066812A5073813408 @default.
• W3096066812 hasAuthorship W3096066812A5079603574 @default.
• W3096066812 hasConcept C104317684 @default.
• W3096066812 hasConcept C111829193 @default.
• W3096066812 hasConcept C125418893 @default.
• W3096066812 hasConcept C126322002 @default.
• W3096066812 hasConcept C138626823 @default.
• W3096066812 hasConcept C143998085 @default.
• W3096066812 hasConcept C170493617 @default.
• W3096066812 hasConcept C203014093 @default.
• W3096066812 hasConcept C2777542201 @default.
• W3096066812 hasConcept C2778461978 @default.
• W3096066812 hasConcept C2778904597 @default.
• W3096066812 hasConcept C2781107101 @default.
• W3096066812 hasConcept C2909962599 @default.
• W3096066812 hasConcept C30481170 @default.
• W3096066812 hasConcept C42362537 @default.
• W3096066812 hasConcept C43907098 @default.
• W3096066812 hasConcept C53226629 @default.
• W3096066812 hasConcept C54355233 @default.
• W3096066812 hasConcept C71924100 @default.
• W3096066812 hasConcept C86803240 @default.
• W3096066812 hasConceptScore W3096066812C104317684 @default.
• W3096066812 hasConceptScore W3096066812C111829193 @default.
• W3096066812 hasConceptScore W3096066812C125418893 @default.
• W3096066812 hasConceptScore W3096066812C126322002 @default.
• W3096066812 hasConceptScore W3096066812C138626823 @default.
• W3096066812 hasConceptScore W3096066812C143998085 @default.
• W3096066812 hasConceptScore W3096066812C170493617 @default.
• W3096066812 hasConceptScore W3096066812C203014093 @default.
• W3096066812 hasConceptScore W3096066812C2777542201 @default.
• W3096066812 hasConceptScore W3096066812C2778461978 @default.
• W3096066812 hasConceptScore W3096066812C2778904597 @default.
• W3096066812 hasConceptScore W3096066812C2781107101 @default.
• W3096066812 hasConceptScore W3096066812C2909962599 @default.
• W3096066812 hasConceptScore W3096066812C30481170 @default.
• W3096066812 hasConceptScore W3096066812C42362537 @default.
• W3096066812 hasConceptScore W3096066812C43907098 @default.
• W3096066812 hasConceptScore W3096066812C53226629 @default.
• W3096066812 hasConceptScore W3096066812C54355233 @default.
• W3096066812 hasConceptScore W3096066812C71924100 @default.
• W3096066812 hasConceptScore W3096066812C86803240 @default.
• W3096066812 hasIssue "Supplement 1" @default.
• W3096066812 hasLocation W30960668121 @default.
• W3096066812 hasOpenAccess W3096066812 @default.
• W3096066812 hasPrimaryLocation W30960668121 @default.
• W3096066812 hasRelatedWork W140728922 @default.
• W3096066812 hasRelatedWork W1530124219 @default.
• W3096066812 hasRelatedWork W1991837960 @default.
• W3096066812 hasRelatedWork W2012047949 @default.
• W3096066812 hasRelatedWork W2059525737 @default.
• W3096066812 hasRelatedWork W2066424928 @default.
• W3096066812 hasRelatedWork W2070906996 @default.
• W3096066812 hasRelatedWork W2183840240 @default.
• W3096066812 hasRelatedWork W2352528894 @default.
• W3096066812 hasRelatedWork W4318542694 @default.
• W3096066812 hasVolume "136" @default.
• W3096066812 isParatext "false" @default.
• W3096066812 isRetracted "false" @default.
• W3096066812 magId "3096066812" @default.
• W3096066812 workType "article" @default.